Home › Research › Cognitive tests and assessment
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
K. A. Welsh, Nelson Butters, Richard C. Mohs, Duane L. Beekly, Steven D. Edland, Gerda G. Fillenbaum, Albert Heyman. Neurology, 1994-04-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The neuropsychological tests developed for the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) are currently used to measure cognitive impairments of Alzheimer's disease (AD) in clinical investigations of this disorder. This report presents the normative information for the CERAD battery, obtained in a large sample (n = 413) of control subjects (ages 50 to 89) who were enrolled in 23 university medical centers in the United States participating in the CERAD study from 1987 to 1992. We compared separately the performance of subjects with high (> or = 12) and low (< 12) years of formal education. For many of the individual cognitive measures in the highly educated group, we observed significant age and gender effects. Only the praxis measure showed a significant age effect in the low-education group. Delayed recall, when adjusted for amount of material acquired (savings), was relatively unaffected by age, gender, and level of education. Our findings suggest that the savings scores, in particular, may be useful in distinguishing between AD and normal aging.
What this study adds
Evidence grade: Not rated
Reports normal reference scores for the CERAD neuropsychological test battery from 413 control participants aged 50 to 89. In the more educated group, age and gender affected many test scores, while delayed recall adjusted for the amount of material learned (savings) was relatively unaffected by age, gender and education.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D. L., Edland, S. D., Fillenbaum, G. G., et al. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. https://doi.org/10.1212/wnl.44.4.609
Vancouver
Welsh KA, Butters N, Mohs RC, Beekly DL, Edland SD, Fillenbaum GG, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994. doi:10.1212/wnl.44.4.609. PMID: 8164812.
BibTeX
@article{welsh1994-8164812,
author = {Welsh, K. A. and Butters, Nelson and Mohs, Richard C. and Beekly, Duane L. and Edland, Steven D. and Fillenbaum, Gerda G. and Heyman, Albert},
title = {{The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery}},
journal = {Neurology},
year = {1994},
doi = {10.1212/wnl.44.4.609},
pmid = {8164812},
url = {https://doi.org/10.1212/wnl.44.4.609}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Why it matters
Reports normal reference scores for the CERAD neuropsychological test battery from 413 control participants aged 50 to 89. In the more educated group, age and gender affected many test scores, while delayed recall adjusted for the amount of material learned (savings) was relatively unaffected by age, gender and education. The authors suggest savings scores may help distinguish Alzheimer's disease from normal aging.
How this study scored 47/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on strength of evidence, so that was left out: it earned 45 of the 95 points we could judge it on, which is 47 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | — / 5 | No evidence rating recorded — left out of this score |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1994 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 959 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 28.2 citations a year over 34 year(s) since 1994 |
| Impact for its field and year | 3 / 6 | Cited 7.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 81 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Albert Heyman: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Duke Medical Center: institution h-index 1,255 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8164812) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 45 / 95 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 45 of the 95 points we could judge it on is 47 out of 100. |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Cognitive tests and assessment from nearby years
Also in Cognitive tests and assessment
92 studies in the library are filed under Cognitive tests and assessment with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Cognitive tests and assessment hub.